Revance Therapeutics, Inc. today announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units to 29 employees. The RSUs vest over four years, with 25% of the.
Revance Therapeutics, Inc. today announced new hire grants totaling an aggregate of 222,452 inducement restricted stock units ("RSUs") to 29 employees. The RSUs vest over four years, with 25% of the underlying shares vesting on each of the four.